These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7570893)

  • 21. Efficacy of ketoconazole in post-kala-azar dermal leishmaniasis.
    Ramesh V; Saxena U; Misra RS
    Arch Dermatol; 1992 Mar; 128(3):411-2. PubMed ID: 1550382
    [No Abstract]   [Full Text] [Related]  

  • 22. Visceral leishmaniasis with concomittant post kala-azar dermal leishmaniasis responds to oral sitamaquine: case report.
    Mbui J; Rashid R; Lodenyo H; Nyakundi P; Kipmutai R; Mutuma G; Kirigi G; Kinoti D; Wasunna M
    East Afr Med J; 2003 Aug; 80(8):440-2. PubMed ID: 14601788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of Post-kala-azar dermal leishmaniasis.
    Ono H; Ghoreishi M; Yokozeki H; Katayama I; Nishioka K
    J Dermatol; 1998 Feb; 25(2):118-20. PubMed ID: 9563280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient.
    Ramos A; Cruz I; Muñez E; Salas C; Fernández A; Alvarez-Espejo T
    Infection; 2008 Mar; 36(2):184-6. PubMed ID: 18327683
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute uveitis: A rare adverse effect of miltefosine in the treatment of post-kala-azar dermal leishmaniasis.
    Pandey K; Pal B; Topno RK; Lal CS; Das VNR; Das P
    Rev Soc Bras Med Trop; 2020; 54():e20200208. PubMed ID: 33338118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment.
    el Hassan AM; Ghalib HW; Zijlstra EE; Eltoum IA; Satti M; Ali MS; Ali HM
    Trans R Soc Trop Med Hyg; 1992; 86(3):245-8. PubMed ID: 1329273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post kala-azar dermal leishmaniasis (PKDL): a first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Indian J Pathol Microbiol; 2003 Apr; 46(2):214-5. PubMed ID: 15022913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allopurinol therapy in post-kala-azar dermal leishmaniasis.
    Ramesh V
    Acta Derm Venereol; 1996 Jul; 76(4):328-9. PubMed ID: 8869699
    [No Abstract]   [Full Text] [Related]  

  • 30. To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL).
    Rabi Das VN; Siddiqui NA; Pal B; Lal CS; Verma N; Kumar A; Verma RB; Kumar D; Das P; Pandey K
    PLoS One; 2017; 12(3):e0174497. PubMed ID: 28355259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-kala-azar dermal Leishmaniasis in two different clinical contexts.
    Barroso DH; Silva CE; Perdigao e Vasconcelos AC; Cavalcanti SM; Brito ME; Medeiros AC
    An Bras Dermatol; 2015; 90(3 Suppl 1):108-10. PubMed ID: 26312689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh.
    Rahman KM; Islam S; Rahman MW; Kenah E; Ghalib CM; Zahid MM; Maguire J; Rahman M; Haque R; Luby SP; Bern C
    Clin Infect Dis; 2010 Jan; 50(1):73-6. PubMed ID: 19951168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of a combination of two antifungal drugs, terbinafine plus itraconazole, in Sudanese post kala-azar dermal leishmaniasis.
    Khalil EA; Nur NM; Zijlstra EE; El-Hassan AM; Davidson RN
    Trans R Soc Trop Med Hyg; 1996; 90(2):187-8. PubMed ID: 8761586
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis in patients coinfected with the human immunodeficiency virus.
    Torre-Cisneros J; Villanueva JL
    Clin Infect Dis; 1995 Jan; 20(1):191. PubMed ID: 7727652
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypokalaemia-induced rhabdomyolysis after treatment of post-Kala-azar dermal Leishmaniasis (PKDL) with high-dose AmBisome in Bangladesh-a case report.
    Marking U; den Boer M; Das AK; Ahmed EM; Rollason V; Ahmed BN; Davidson RN; Ritmeijer K
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2864. PubMed ID: 24922279
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of intermittent liposomal amphotericin B in the treatment of visceral leishmaniasis in patients infected with human immunodeficiency virus.
    Laguna F; Torre-Cisneros J; Moreno V; Villanueva JL; Valencia E
    Clin Infect Dis; 1995 Sep; 21(3):711-2. PubMed ID: 8527591
    [No Abstract]   [Full Text] [Related]  

  • 37. Post kala-azar dermal leishmaniasis: the Kenyan experience.
    Muigai R; Gachihi GS; Oster CN; Were JB; Nyakundi PM; Chunge CN; Kirigi G; Rashid JR
    East Afr Med J; 1991 Oct; 68(10):801-6. PubMed ID: 1667521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis.
    Brown M; Noursadeghi M; Boyle J; Davidson RN
    Br J Dermatol; 2005 Jul; 153(1):203-5. PubMed ID: 16029352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-kala-azar dermal leishmaniasis: a clinical and therapeutic study.
    Ramesh V; Misra RS; Saxena U; Mukherjee A
    Int J Dermatol; 1993 Apr; 32(4):272-5. PubMed ID: 8387467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kala-azar associated with coombs-positive autoimmune hemolytic anemia in the patients coming from the endemic area of this disease and successful treatment of these patients with liposomal amphotericin B.
    Erduran E; Bahadir A; Gedik Y
    Pediatr Hematol Oncol; 2005; 22(5):349-55. PubMed ID: 16020124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.